TRON-Translationale Onkologie an der Universitätsmedizin der JGU Mainz gGmbH: Translational Oncology – Driving innovation for future pharmaceuticals

_DSC1867-Kopie

 

 

 

 

 

TRON is a non-profit transdisciplinary research institute based at the Univer­­sity Medical Center of the Johannes Guten­­berg University Mainz. TRON’s main task is performing basic and application-oriented research in the areas of oncology and immunology while acting as a step­­ping stone to product development. At the interface between science and busi­­ness, TRON focuses on the quick translation of research into diagnostic products, pharmaceuticals and therapies for treating cancer and diseases with high medical need.

TRON offers a unique infrastructure for product-oriented research in the dynamic scientific environment afforded by Mainz. The institute employs an international team of over 80 researchers, technology experts and physicians. As a driver of in­­novation, TRON supports bio-tech companies in the region with its research work, particularly in the area of highly specialised functions, which allows the companies to focus on their core competencies and product development.

Institutional shareholders of TRON in­clude the German Federal State of Rhine­­land-Palatinate, the Johannes Guten­­berg University Mainz and the Uni­­versity Med­ical Center of the Johannes Gutenberg Uni­­versity Mainz.



  1. Address

    Langenbeckstraße 1
    Verfügungsgebäude 708 (3. OG)
    55131 Mainz
    Telefon +49 6131 17-8053
    Fax +49 6131 17-8055
    front-office@tron-mainz.de
    www.tron-mainz.de
  2. Management

    Prof. Dr. Ugur Sahin
    Founder and Managing Director Science and Research)

    Dipl.-Kfm. Michael Föhlings
    (Chief Financial Officer)
  3. Year of establishment

    2010
  4. Employees

    117
  5. Business activity

    Basic and application-oriented research into diagnostic products, pharmaceuticals and therapies for treating cancer and diseases with high medical need